​
​

Viridian Therapeutics Ownership | Who Owns Viridian Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Viridian Therapeutics Ownership Summary

Viridian Therapeutics is owned by 113.75% institutional investors, 0.01% insiders. Fmr is the largest institutional shareholder, holding 15.67% of VRDN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.81% of its assets in Viridian Therapeutics shares.

VRDN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockViridian Therapeutics113.75%0.01%-13.75%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr9.57M15.67%$124.55M
Blackrock4.77M7.81%$62.10M
Deep track capital, lp3.92M6.42%$51.05M
Vr adviser3.88M6.35%$50.51M
Vanguard group3.35M5.48%$43.53M
Maverick capital3.31M5.41%$43.04M
Paradigm biocapital advisors lp2.90M4.74%$37.68M
State street2.77M4.54%$36.07M
Commodore capital lp2.53M4.14%$32.89M
Novo2.00M3.27%$26.02M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Vr adviser3.88M3.22%$50.51M
Fairmount funds management1.85M2.71%$24.01M
Ghost tree capital587.71K2.39%$7.65M
Commodore capital lp2.53M2.25%$32.89M
5am venture management736.60K2.14%$9.58M
Vivo capital1.68M2.02%$21.83M
Tang capital management1.39M1.85%$18.12M
Kynam capital management, lp1.75M1.76%$22.77M
Kopp family office205.74K1.66%$2.68M
Deep track capital, lp3.92M1.52%$51.05M

Top Buyers

HolderShares% AssetsChange
Kynam capital management, lp1.75M1.76%1.62M
Blackrock4.77M0.00%960.99K
Novo2.00M1.31%900.00K
Tang capital management1.39M1.85%700.00K
Maverick capital3.31M0.82%615.53K

Top Sellers

HolderShares% AssetsChange
Paradigm biocapital advisors lp2.90M1.44%-2.14M
Perceptive advisors1.63M0.50%-2.03M
State street2.77M0.00%-1.72M
Polar capital---889.20K
Great point partners500.00K1.25%-835.00K

New Positions

HolderShares% AssetsChangeValue
Trexquant investment lp41.82K0.01%41.82K$544.13K
Corebridge financial33.66K0.00%33.66K$437.97K
Mirae asset global etfs31.49K0.00%31.49K$408.43K
Macquarie group29.37K0.00%29.37K$382.00K
Bayesian capital management, lp28.68K0.04%28.68K$373.15K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-8.00
Game plan financial advisors-13.00
Fortitude family office-29.00
Harbour investments-66.00
Lindbrook capital-187.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20241462.10%69,497,343-1.95%1130.85%892.30%29-12.12%
Mar 31, 20241432.88%70,881,26917.87%1160.79%8719.18%33-25.00%
Dec 31, 202313910.32%60,136,74819.81%1210.92%735.80%4425.71%
Sep 30, 2023126-11.27%50,192,4246.27%1140.96%69-23.33%3540.00%
Jun 30, 2023142-2.07%47,229,0869.72%1091.05%907.14%25-32.43%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.23M2.81%-15.41K
Fidelity Select Health Care1.95M2.56%453.03K
iShares Russell 2000 ETF1.60M2.10%-3.61K
Fidelity Advisor Biotechnology I1.39M1.82%107.60K
Fidelity Select Biotechnology1.30M1.70%289.39K
Fidelity Advisor Health Care I1.20M1.57%200.00K
AB Small Cap Growth A1.03M1.35%22.82K
FIAM Small Cap Core CIT Cl B1.01M1.32%6.88K
SPDR® S&P Biotech ETF999.75K1.31%11.05K
FIAM Small Cap Core Composite996.28K1.30%273.68K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 27, 2024Beetham Thomas W. Chief Operating OfficerBuy$117.05K
Sep 27, 2024Mahoney Stephen F. President and CEOBuy$499.26K
Sep 13, 2024Fairmount Funds Management LLC Buy$30.00M
Jan 22, 2024Fairmount Funds Management LLC See RemarksBuy$10.00M
Jun 16, 2023Meisner Lara Chief Legal OfficerSell$765.45

Insider Transactions Trends

DateBuySell
2024 Q2--
2024 Q11-
2023 Q4--
2023 Q3--
2023 Q215

VRDN Ownership FAQ

Who Owns Viridian Therapeutics?

Viridian Therapeutics shareholders are primarily institutional investors at 113.75%, followed by 0.01% insiders and -13.76% retail investors. The average institutional ownership in Viridian Therapeutics's industry, Biotech Stocks , is 44.97%, which Viridian Therapeutics exceeds.

Who owns the most shares of Viridian Therapeutics?

Viridian Therapeutics’s largest shareholders are Fmr (9.57M shares, 15.67%), Blackrock (4.77M shares, 7.81%), and Deep track capital, lp (3.92M shares, 6.42%). Together, they hold 29.90% of Viridian Therapeutics’s total shares outstanding.

Does Blackrock own Viridian Therapeutics?

Yes, BlackRock owns 7.81% of Viridian Therapeutics, totaling 4.77M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 62.1M$. In the last quarter, BlackRock increased its holdings by 960.99K shares, a 25.21% change.

Who is Viridian Therapeutics’s biggest shareholder by percentage of total assets invested?

Vr adviser is Viridian Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.22% of its assets in 3.88M Viridian Therapeutics shares, valued at 50.51M$.

Who is the top mutual fund holder of Viridian Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Viridian Therapeutics shares, with 2.81% of its total shares outstanding invested in 2.23M Viridian Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools